| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.1M | -80.1% |
| Cost of Revenue | $5.8M | -82.7% |
| Gross Profit | $5.3M | -76.3% |
| R&D Expense | $559K | -85.5% |
| SG&A Expense | $4.4M | -36.6% |
| Operating Income | -$13.1M | +37.0% |
| Pre-tax Income | -$15.7M | +38.7% |
| Income Tax | $318K | -72.1% |
| Net Income | -$17.5M | +34.7% |
| EPS (Basic) | -$29.33 | -631.4% |
| EPS (Diluted) | -$29.33 | -631.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.4M | +185.7% |
| Accounts Receivable | $1.1M | +3.5% |
| Current Assets | $11.1M | -88.3% |
| Total Assets | $13.1M | -89.3% |
| Current Liabilities | $10.0M | -90.3% |
| Total Liabilities | $12.4M | -90.0% |
| Stockholders' Equity | $668K | +144.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.0M | -208.7% |
| Capital Expenditures | $79K | +68.1% |
| Investing Cash Flow | -$76.3M | -4122.9% |
| Financing Cash Flow | $13.9M | +5863.1% |
| Free Cash Flow | -$23.1M | -209.3% |